HIGHFDA DRUG

Sun Pharmaceutical Radiopharmaceutical Kit Recall: 1,870 Kits Recalled for OOS Dissolution Issue

Sun Pharmaceutical Industries recalled 1,870 kits nationwide after an out-of-specification dissolution test for sulphate in Sodium Tartrate Dihydrate used to produce Mertiatide. The recall affects Rx-only kits distributed across the U.S. Healthcare providers and patients should stop using the product immediately and follow guidance from Sun Pharmaceutical. Contact information is provided by the UQ

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
September 3, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
September 3, 2025
Hazard Level
HIGH
Brand
Sun Pharmaceutical Industries
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT, PETS

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Sun Pharmaceutical Industries
Product type
Radionuclide kit or radiopharmaceutical preparation kit
Model numbers
Lot AD70995
UPC codes
45567-0655, 45567-0655-1
Sold at
Unknown
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    September 3, 2025

  2. Reported by FDA DRUG

    September 24, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Failed Dissolution Specifications-Out of Specification (OOS) observation for sulphate in Sodium Tartrate Dihydrate used for the production of Mertiatide.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact SUN PHARMACEUTICAL INDUSTRIES INC or your healthcare provider for guidance. Notification method: Letter

About This Product

Radiopharmaceutical kits like this enable clinicians to prepare Tc-99m Mertiatide for imaging. They are Rx-only and used in medical facilities.

Why This Is Dangerous

An out-of-spec dissolution in a component could compromise product quality and patient safety, though no injuries reported yet.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Immediate stop-use and notification are required to prevent potential compromised imaging agents.

Practical Guidance

How to identify if yours is affected

  1. Check lot AD70995 and expiry 10/31/2025 on the kit packaging.
  2. Verify NDC 45567-0655-1 and product name.
  3. Confirm nationwide distribution status.

Where to find product info

Recall notice on FDA enforcement site and Sun Pharmaceutical communications.

What timeline to expect

Refunds or replacements typically follow standard drug recall timelines (variable by distributor).

If the manufacturer is unresponsive

  • Escalate to FDA recall contacts
  • File a consumer complaint with CPSC if applicable
  • Consult hospital's recall coordinator

How to prevent similar issues

  • Implement robust lot-tracking and quarantine processes for radiopharmaceuticals
  • Verify dissolution specs in incoming components
  • Strengthen supplier qualification and lot release testing

Documentation advice

Keep recall notice, lot AD70995, expiry date, and all correspondence with Sun Pharmaceutical.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Brand: Sun Pharmaceutical Industries. Product: Kit for the Preparation of Technetium Tc 99m Mertiatide. NDC: 45567-0655-1. Lot: AD70995. Expiry: 10/31/2025. Quantity: 1870 kits. Distribution: US Nationwide. Type: Rx-only radiopharmaceutical preparation kit.

Reported Incidents

No specific patient injuries or incidents reported in the available data.

Key Facts

  • Nationwide distribution in the U.S.
  • OOS dissolution issue for sulphate in Sodium Tartrate Dihydrate

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALPREGNANTPETSPREGNANTINFANTSCHILDREN
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Lot AD70995
UPC Codes
45567-0655
45567-0655-1
Affected States
ALL
Report Date
September 24, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more